New NASDAQ Alert [Inside]

AwesomeStocks “Sponsored on behalf of BYND Cannasoft Enterprises Inc.” Hello! New Alert: BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) BCAN is our brand new NASDAQ alert that could present a breakout opportunity. BCAN has a chart setup suggesting the potential for high gains. In addition, BCAN announced multiple breaking developments recently that could be growth catalysts for the company. BCAN is a NASDAQ listed “Israeli-based integrated software and cannabis company”. BCAN “owns and markets "Benefit CRM," a proprietary customer relationship management (CRM) software product enabling small and medium‐sized businesses to optimize their day‐to‐day business activities such as sales management, personnel management, marketing, call center activities, and asset management”. Building on the company’s “20 years of experience in CRM software”, BCAN is “developing an innovative new CRM platform to serve the needs of the medical cannabis industry by making it a more organized, accessible, and price-transparent market”. As the company further explains: “The Cannabis CRM System will include a Job Management (BENEFIT) and a module system (CANNASOFT) for managing farms and greenhouses with varied crops.” In addition, BCAN “owns the patent-pending intellectual property for the EZ-G device”. This “therapeutic device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women's health issues”. As the company explains, “The EZ-G device includes technological advancements as a sex toy with a more realistic experience and the prototype utilizes sensors to determine what enhances the users' pleasure”. Furthermore: “The user can control the device through a Bluetooth app installed on a smartphone or other portable device.” “The data will be transmitted and received from the device to and from the secure cloud using artificial intelligence (AI). The data is combined with other antonymic user preferences to improve its operation by increasing sexual satisfaction.” The burgeoning field of wearable technology has witnessed remarkable growth in recent years. Importantly: “While most people associate wearables with fitness trackers and smartwatches, there is an emerging trend in wearable sex toys.” “The allure of discreet public stimulation combined with the pleasure of a sex toy has contributed to the rise of this trend.” BCAN, “recognizing the potential in the sextech market, intends to capitalize on this growth”. According to the company, “Industry experts project the sextech market to reach $62.32 billion by 2030, and companies, including BYND Cannasoft, are actively innovating products with intelligent responses for sexual activities to meet the demands of this expanding market, as reported by Forbes”. BCAN has announced multiple accomplishments recently that could be significant growth catalysts for the company. On July 10, the company announced: “BYND Cannasoft Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization” “With the positive outcomes achieved during the trial, BYND Cannasoft is now committed to finalizing the EZ-G prototype model and progressing to the next phase of development: human trials involving focus groups of women of different age groups.” “The Company remains committed to ensuring the EZ-G device meets the highest safety, efficacy, and usability standards. Through continued research and development efforts, BYND Cannasoft aims to contribute to the well-being of women by providing an innovative solution for targeted health concerns.” Here are some of the company’s comments from this press release: "We are thrilled with the successful completion of the laboratory testing phase for the EZ-G device," said Yftah Ben Yaackov, CEO and Director of BYND Cannasoft. "This accomplishment validates our dedication to harnessing advanced technology to improve women's health. We are excited to move forward with human trials, as we believe the EZ-G device has the potential to revolutionize therapeutic approaches for women's health issues." In addition, two weeks ago, the company announced: “BYND Cannasoft Closes US$2.6 Million Underwritten Public Offering” “The Company intends to use the net proceeds from this offering primarily for product design and manufacturing, sales and marketing campaigns, patent prosecution and working capital.” Last week, the company announced some groundbreaking milestones: “BYND Cannasoft Provides EZ-G Device Milestones for the Second Half of 2023” “BYND Cannasoft is pleased to provide the following key milestones in the development of the EZ-G Device:” - “Finishing the Prototype of the EZ-G Device in 60 Days: BYND Cannasoft plans to reiterate its commitment to innovation by accomplishing the development of the EZ-G Device's initial prototype within a 60-day timeline. The Company’s team of experts intends to create a prototype that showcases the technology's potential to disrupt the market.” - “EZ-G Device Focus Group Experience within 60 Days: In line with BYND Cannasoft's customer-centric approach, the Company plans to engage a focus group to perform rigorous testing and evaluation of the EZ-G Device over the next 60 days. This process will provide valuable insights and user feedback, helping to refine the product to exceed customer expectations.” - “Finalizing the EZ-G Device Prototype and Software by the End of the Fourth Quarter: Building upon insights gained from the focus group, BYND Cannasoft intends to build on its recent successful completion of the laboratory testing phase by fine-tuning the EZ-G Device's prototype and software. The Company is dedicated to refining user experience and functionality to introduce a superior product.” - “Going to Market with the EZ-G Device in the First Quarter of 2024: With a meticulously developed and thoroughly tested product, BYND Cannasoft’s management believes the Company is on track for a market launch of the EZ-G Device in the first quarter of 2024. The Company anticipates that the product will set new industry benchmarks.” In addition, as the company explains, BCAN is “actively negotiating with several companies with synergistic business models, particularly those in the CBD oils sector”. “These discussions aim to establish transformative partnerships, opening doors for new opportunities and amplifying the impact of both companies in the market.” Here are some of the company’s comments from this press release: “Yftah Ben Yaackov, CEO and Director of BYND Cannasoft said, "As part of the prototype development of the EZ-G device, numerous comprehensive experiments were conducted during the recent laboratory testing phase to assess the functionality and performance of the assembled sensors within the device that are capable of detecting indicators such as temperature, heart rate, contractions, and fluids. Our next phase will include completing the prototype, engaging in feedback from various focus groups, and solidifying strategic agreements to bring the EZ-G Device to market." Mr. Ben Yaackov continued, "This is an excellent example of our commitment to delivering exceptional products and experiences to our customers. Our relentless focus on innovation and customer satisfaction continues to drive our success, positioning BYND Cannasoft as a trailblazer in the women's health industry.”” But that’s not all… On Monday, the company announced breaking news that could be an important growth catalyst: “Israeli Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device” As the company further explains: “In addition to potentially treating certain issues in the female reproductive system, the EZ-G device incorporates technological advancements as a sex toy, providing a more realistic experience. Equipped with sensors such as a pressure sensor, temperature sensor, conductivity sensor, and heart rate sensor, the EZ-G device prototype aims to identify specific factors that enhance users' pleasure. Through the use of artificial intelligence (AI), the device transmits and receives data from these sensors, capturing information about the conditions of the user's sexual organs, including moisture levels and muscle contractions' pressure variations.” Here are some of the company’s comments from this press release: "Filing our latest patent with the World Intellectual Property Organization is a testament to our unwavering commitment to innovation and technological advancement in the field of artificial intelligence and machine learning," stated Yftah Ben Yaackov, CEO and Director of BYND Cannasoft. "The technology behind our EZ-G device showcases our commitment to shaping the future of machine learning, as well as reflects the dedication and expertise of our talented team. We are excited about its potential impact on women's health worldwide." BCAN has multiple potential catalysts in its favor to experience increased growth. Make sure to do your own due diligence. Sources: [PR1]( [PR2]( [PR3]( [PR4]( [Website]( [Chart]( Happy Trading! AwesomeStocks Note: We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose. DISCLAIMER You should read and understand this disclaimer in its entirety before joining the website or email/blog list of AwesomeStocks.com (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help. The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at www.sec.gov; the Financial Industry Regulatory Authority (the "FINRA") at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete. The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete. Owners and operators of the Publisher have been compensated thirteen thousand one hundred twenty five dollars by bank wire transfer on 7/26/23 for the distribution of this advertisement about BCAN dated 8/2/23. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time. You are receiving this report/release because you subscribed to receive it at our website or through a third-party site. All our newsletters include an "unsubscribe" link, and you can remove yourself at any time from our newsletters by clicking on that "unsubscribe" link. You can also contact us at info@AwesomeStocks.com to change your information at any time. By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: www.AwesomeStocks.com/Disclaimer and www.AwesomeStocks.com/Privacy-Policy By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. Our records indicate that {EMAIL} requested and confirmed to be added to AwesomeStocks.com on March 5, 2023. [Click Here To Unsubscribe]( 6020 Bent Pine Dr Orlando Florida 32822 USA [Unsubscribe]( | [Change Subscriber Options](